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Systematic review of misdiagnosis of conversion symptoms and
“hysteria”
Jon Stone, Roger Smyth, Alan Carson, Steff Lewis, Robin Prescott, Charles Warlow, Michael Sharpe
Abstract
Objective Paralysis, seizures, and sensory symptoms that are
unexplained by organic disease are commonly referred to as
“conversion” symptoms. Some patients who receive this
diagnosis subsequently turn out to have a disease that explains
their initial presentation. We aimed to determine how
frequently this misdiagnosis occurs, and whether it has become
less common since the widespread availability of brain imaging.
Design Systematic review.
Data sources Medline, Embase, PsycINFO, Cinahl databases,
and searches of reference lists.
Review methods We included studies published since 1965 on
the diagnostic outcome of adults with motor and sensory
symptoms unexplained by disease. We critically appraised these
papers, and carried out a multivariate, random effect,
meta-analysis of the data.
Results Twenty seven studies including a total of 1466 patients
and a median duration of follow-up of five years were eligible
for inclusion. Early studies were of poor quality. There was a
significant (P < 0.02) decline in the mean rate of misdiagnosis
from the 1950s to the present day; 29% (95% confidence
interval 23% to 36%) in the 1950s; 17% (12% to 24%) in the
1960s; 4% (2% to 7%) in the 1970s; 4% (2% to 6%) in the 1980s;
and 4% (2% to 6%) in the 1990s. This decline was independent
of age, sex, and duration of symptom in people included in the
studies.
Conclusions A high rate of misdiagnosis of conversion
symptoms was reported in early studies but this rate has been
only 4% on average in studies of this diagnosis since 1970. This
decline is probably due to improvements in study quality rather
than improved diagnostic accuracy arising from the
introduction of computed tomography of the brain.
Introduction
Patients with motor and sensory symptoms—such as paralysis,
seizures, and blindness—that are unexplained by disease remain
commonplace in neurological practice and account for 1-9% of
inpatients and outpatients.1 Modern psychiatric diagnostic classi-
fications use the term conversion disorder (Diagnostic and Statis-
tical Manual of Mental Disorders, fourth edition (DSM-IV) or
dissociative motor disorder (ICD-10, international classification
of diseases, 10th revision) for symptoms that suggest a
neurological diagnosis but are not due to disease or malingering.
They have also been called “psychogenic,” “non-organic,”
“hysterical,” “medically unexplained,” and sometimes “func-
tional” symptoms, though we have called them all conversion
symptoms here.
Doctors often feel uneasy about making a diagnosis of
conversion symptoms. This is, in part, due to the considerable
influence of studies that have suggested that misdiagnosis is
unacceptably common. The best known of these studies was
published by Slater in 1965. It described a misdiagnosis rate of
33% in patients with “hysteria” and concluded with the memora-
ble warning that the diagnosis was nothing more than “a
delusion and a snare.”2
We carried out a systematic review of all relevant studies pub-
lished since 1965 to obtain the best estimate of how often
patients with an initial diagnosis of conversion symptoms are
subsequently given a disease diagnosis that, in hindsight,
explained their original symptoms. We also investigated whether
the rate of misdiagnosis is lower in more recent studies,
especially those carried out since the widespread availability of
brain imaging.
Methods
Search strategy for studies
We searched Medline (from 1966), CINAHL (from 1982),
Embase (from 1980), and PsycINFO (from 1965) to December
2003. We used all database controlled vocabulary headings for
conversion disorder and hysteria and the text words psychoso-
matic, psychogenic, somatization, unexplained, conversion, non-
organic, dissoc*. They were combined with text words for
paralysis, paresis, sensory disturbance, deafness, hearing, vis*,
blind*, and movement disorders. References for pseudoseizures
were searched with the text words: pseudoseizure, non-epileptic,
psychogenic seizure, hysterical attack. All references under the
heading “conversion disorder” or with the text word hysteri*
were also examined. We reviewed the titles and abstracts online
and obtained copies of all publications that might conceivably
contain relevant data. The reference lists of all these publications
were also examined for additional relevant studies published
after 1965.
Study inclusion and exclusion
We included studies if the participants were aged > 16;
symptoms were described as medically unexplained, non-
organic, psychogenic, hysterical, conversion, or functional; the
symptoms described were motor (paresis, paralysis, movement
disorder, gait disorder), sensory (numbness or paraesthesia), loss
of vision, loss of hearing, or episodes resembling epilepsy (pseu-
doseizures); the study was of more than 10 patients; and there
was a follow-up period of more than six months, at which time
some attempt was made to review the accuracy of the initial
diagnosis. We excluded studies of patients with other
somatoform diagnoses including somatoform pain disorder and
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somatisation disorder (multiple chronic symptoms unexplained
by a general medical condition attributable to several bodily sys-
tems). No studies were excluded on the basis of language.
We considered that a misdiagnosis of conversion disorder
had occurred when the investigators concluded that, with
hindsight, most of a patient’s original symptoms or signs were
better explained by a disease. We used the term “disease” to
describe a clearly defined pathology (for example, stroke) or a
diagnosis that is generally accepted as a medical condition (for
example, migraine, dystonia).We did not record a misdiagnosis if
the patient had an initial diagnosis of disease with a comorbid
diagnosis of “hysteria” that was subsequently revised to a diagno-
sis of disease alone. Neither did we record psychiatric
misdiagnosis. A symptom such as leg paralysis cannot in
hindsight be attributed to another psychiatric diagnosis such as
depression even if comorbid depression was missed at the time
of initial diagnosis.
Data extraction and analysis
Four investigators (JS, RS, AC, and MS) independently reviewed
all reports and a fifth (CW) arbitrated in cases of disagreement.
We collected data on the nature of the symptoms; the sex and
mean age of the participants; the setting in which the patient was
seen; whether sampling was consecutive or non-consecutive, and
retrospective or prospective; the years in which the patients ini-
tially received the diagnosis; the duration and completeness of
follow-up; the method of diagnosis used at follow-up; and the
frequency and nature of any misdiagnoses and causes of death
(where this was recorded). We attempted to contact authors to
clarify data when these were uncertain.
We calculated the rate of misdiagnosis in each study as the
“number of patients misdiagnosed” divided by the “number of
patients followed up including those who died.” Firstly, we deter-
mined an overall rate of misdiagnosis both by simple pooling of
the data and by a random effects model. Secondly, we
summarised the data according to the date the initial
“conversion” diagnosis was made (rather than study publication
date). If the dates of recruitment of patients were unavailable we
estimated them using the published mean or range of duration
of follow-up (allowing one extra year for publication). We
summarised these data by charting individual studies according
to the midpoint of their recruitment period, and, because this
may not reflect adequately the wide variation in the duration of
patient recruitment, we also calculated the proportion of patients
with a misdiagnosis for each five year and ten year time period
from 1950-99 using random effect models. Thirdly, we used a
general linear mixed model to examine the relation between the
proportion of patients with a misdiagnosis and the variables of
age, sex, duration of follow-up, and midpoint of study
recruitment. All analyses were performed with study effects fitted
as random, using PROC GLIMMIX for SAS 9 (SAS Institute,
Cary, NC).
Results
Included and excluded studies
The table shows the 27 studies eligible for inclusion.3–29 Seven
other studies met some of the eligibility criteria but not others
and were excluded: two studies had fewer than ten patients30 31; in
two studies patients were still under investigation when they were
misdiagnosed32 33; in one study conversion hysteria had been a
differential diagnosis only34; in one study most patients were chil-
dren when they were diagnosed35; and one study had only a four
month follow-up period.36
Other reasons for ineligibility were studies that simply
reported comorbidity with a disease diagnosis37–39; studies
reporting the proportion of patients with a specific disease (for
example, dystonia) who had previously received a diagnosis of
hysteria40–43; studies reporting small series of misdiagnosed
patients with no denominator44–46; and follow-up studies not
reporting the presence or absence of misdiagnosis.
Analysis of misdiagnosis
The overall proportion of misdiagnoses for the whole time
period was 8.4% (95% confidence interval 7.1% to 9.9%) with
simple data pooling but 4.2% (2.4% to 7.1%) with the more rig-
orous random effects model. There has been a clear decline in
the rate of misdiagnosis over the past 50 years, from 29% in the
1950s to 17% in the 1960s, 4% in the 1970s, 4% in the 1980s, and
4% in the 1990s (fig 1). This decline was significant with the ran-
dom effects model (P < 0.02) even after adjustment for patient’s
age, sex, and duration of symptoms (none of which were related
to misdiagnosis in this random effects model). Individual studies
were plotted against the midpoint of date of recruitment with an
indication of the case definition used (fig 2).
Quality of studies
Many of the studies, especially earlier ones,3–5 were of poor qual-
ity and ambiguous. If in doubt, we erred on the side of overesti-
mating the rate of misdiagnosis. For example, in Slater’s study,
cases of “cortical atrophy,” deaths caused by “coronary thrombo-
ses . . . related somewhat indirectly with the presenting
symptoms,” and “duodenal and gallbladder disease” were
counted as misdiagnoses even though the presenting symptoms
were not described.2 3 We included the 29 patients reported by
Reed solely because of the sentence “The ‘conversion symptoms’
in this group were such things as pain later found to be due to
inoperable cancer of the uterus” with no further details given.4
Case definition and the nature of the symptom
In eight studies the nature of the conversion or “hysterical”
symptoms was unclear.3–8 16 26 27 Most of these were older studies
of more loosely defined “hysteria.” Although the symptoms were
largely neurological, there were also patients with symptoms
such as abdominal pain that would not now be regarded as con-
version symptoms. We also undertook an analysis of symptom
specific studies to see if the misdiagnosis rate differed between
symptom types. This indicated that the rate of misdiagnosis of
pseudoseizures11–13 17 18 22 23 was similar to that reported for motor
and sensory symptoms10 15 20 21 24 25 28 29 (2.6% (n = 350) v 4.0%
(n = 373), P = 0.28).
Setting
Only two studies were of outpatients,25 29 in whom investigation
may be less intensive, and seven studies were of patients referred
to psychiatrists.4–6 8 14 19 Psychiatric samples are likely to be biased
because they comprise patients whom the neurologist was confi-
dent enough to refer and who were willing to accept a psychiat-
ric referral.
Sampling of study population
Patients were recruited prospectively in only four studies.19 20 24 29
One problem with retrospective studies is that they are often of
patients who have received a diagnosis of “conversion disorder.”
As neurologists rarely use this diagnosis47 these studies are likely
to be biased by including only patients who have seen a psychia-
trist.
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Duration and completeness of follow-up
The median duration of follow-up was five years with a mean
follow-up rate of 86%. Five studies lost more than 30% to follow-
up8 9 11 18 23 25 and in two the number was unknown.5 7
Method of diagnostic re-evaluation
The ideal standard for diagnostic re-evaluation is for the patient
to be examined by an experienced physician (usually a neurolo-
gist) with additional investigations as required. No study clearly
Studies reporting misdiagnosis in conversion disorder, hysteria, or conversion symptoms since 1965
Author
Years of
diagnosis
Follow-up
duration
(months)*
Follow-up
rate
(%)* Symptoms Setting
Method of
diagnostic
re-evaluation
Misdiagnosed/
followed up†
Misdiagnosed
(%)
Slater2 3 1951-5 108 87% Uncertain Neurology,
inpatients
Interview, case note
review, GP
32/97 33%
Reed4 1949-64 136 94% Pain (12.5%), weakness (10%), non-epileptic
seizure/loss of consciousness (9%), fugue (9%),
movement disorder (7.5%), vomiting (3%),
amnesia (2.5%), other conversion/dissociative
(10%), hysteria not otherwise specified (35%)
Psychiatry,
inpatients
Case note review,
self report, GP
29/113 26%
Lewis5 1969-74 114 NA Uncertain Psychiatry,
uncertain
Interview, self
report, GP
4/98 4%
Stefansson6 1960-9 42 100% Weakness (20%), sensory symptom (14%),
non-epileptic seizure/loss of consciousness (14%),
vision (13%), pain (56%), breathing (28%),
deafness (11%)
Psychiatry,
uncertain
Case note review 8/64 13%
Watson7 1964-6 120 NA Uncertain Military hospital,
uncertain
Case note review 10/40 25%
Wig8 1971-2 90 67% Neurological symptom—for example, aphonia,
paresis + episodic possession states
Psychiatry,
outpatients
Interview 3/54 6%
Kathol9 1973-9 48 53% Vision (100%) Ophthalmology
outpatients
Interview, neuro
re-exam
1/ 42 2%
Baker10 1944-84 20 80% Weakness (100%) Neurology,
inpatients
GP 0/16 0%
Meierkord11 1975-89 60 64% Non-epileptic seizure/loss of consciousness
(100%)
Neurology,
inpatients
GP, case note review 0/70 0%
Kristensen12 1977-85 70 100% Non-epileptic seizure/loss of consciousness
(100%)
Neurology,
inpatients
Interview, GP, case
note review
2/28 7%
Betts13 1983-8 60 86% Non-epileptic seizure/loss of consciousness
(100%)
Neurology,
inpatients
Interview, GP 7/97 7%
Chandrasekaran14 1987 60 75% Non-epileptic seizure/loss of consciousness (63%),
weakness (21%), dissociative disorders (16%)
Psychiatry,
outpatients
Interview 0/38 0%
Kent16 1984-6 50 34% Uncertain Inpatients and
outpatients
Interview 4/33 12%
Couprie15 1982-9 54 97% Weakness +/- sensory symptom (73%), gait
(12%), sensory symptom (5%), dysphonia (5%),
vision (2%), movement disorder (2%)
Neurology,
inpatients
Interview 2/58 3%
Walczak17 1991-3 15 71% Non-epileptic seizure/loss of consciousness
(100%)
Neurology,
inpatients
Interview 0/51 0%
Ramani18 1985-94 55 62% Non-epileptic seizure/loss of consciousness
(100%)
Neurology,
uncertain
Interview 0/21 0%
Mace19 1978-80 117 95% Weakness/movement disorder (42%), non-epileptic
seizure/loss of consciousness (37%)
vision/dysphonia (8%), sensory symptom (5%),
amnesia (4%), other (3%)
Psychiatry,
inpatients and
outpatients
Interview 3/75 15%
Binzer20 1992-5 44 100% Weakness (100%) Neurology,
inpatients
Interview, neuro
re-exam
0/30 0%
Crimlisk21 1989-91 72 88% Weakness (48%), movement disorder (52%) Neurology,
inpatients
Interview, neuro
re-exam
3/64 5%
Jongsma22 1991-4 45 85% Non-epileptic seizure/loss of consciousness
(100%)
Neurology,
inpatients
Self report 0/28 0%
Selwa23 1994-6 33.5 67% Non-epileptic seizure/loss of consciousness
(100%)
Neurology,
inpatients
Interview 0/57 0%
Moene24 1991-6 29 100% Weakness/movement disorder (95%), sensory
symptom (5%)
Neurology,
inpatients
Interview, neuro
re-exam
9/85 11%
Feinstein25 1993-9 38 51% Movement disorders (100%) Neurology,
outpatients
Interview 0/45 0%
Schuepbach26 1986-7 60 93% Conversion disorder (100%) Psychosomatic
clinic, inpatients
and outpatients
GP 0/39 0%
Teasell27 1991-2001 ? 100% Conversion disorder (100%, all with disability
requiring rehabilitation)
Rehabilitation,
inpatients
Interview, neuro
re-exam
5/45 11%
Stone28 1985-92 126 82% Weakness (55%), sensory symptom (45%) Neurology,
inpatients
GP, self report 1/49 2%
Toth29 1998-2001 16 88% Weakness+sensory symptom (33%), sensory
symptom (67%)
Neurology,
outpatients
Interview, neuro
re-exam
0/29 0%
NA=not available.
*Median follow-up=58 months; median follow-up rate=86%.
†Number misdiagnosed=(misdiagnoses+death attributable to misdiagnosis)/all patients followed up (alive and dead): 123/1466 (5%).
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met this standard: only six studies reported re-examination by a
physician,9 21 22 24 27 29 and none reported on investigations. Other
studies used only a combination of interview, self report, and
information from general practice records (table). Although one
might expect disease diagnoses such as severe spastic parapare-
sis to be detected by simple reassessment, others may be missed
because they are obscure (for example, paroxysmal hemidysto-
nia21), too mild (for example, mild multiple sclerosis), or because
the initial diagnosis of conversion disorder has prejudiced an
open minded re-evaluation.
Patients with disease and conversion symptoms
Three studies reported on patients who had an initial diagnosis
of both disease and conversion symptoms that was subsequently
revised to one of disease alone.3 19 24 We did not count these 28
cases as misdiagnoses, and additional information from the
author of one study led to two more patients being placed in that
category.19
Nature of misdiagnosis and cause of death
The nature of the revised diagnosis was reported in 68 out of 123
cases. Epilepsy (n = 13), movement disorders (n = 6), and
multiple sclerosis (n = 6) were most common. The presenting
symptom of the misdiagnosed patients was described in 52 cases;
the most common were gait disorder (n = 17), seizures (n = 13),
and movement disorder (n = 5). In the eight cases in which an
initial diagnosis of pseudoseizures was later changed to one of
epilepsy (and in which the seizure type was described), five had
frontal lobe epilepsy—a cause of unusual attacks that can some-
times be missed even by videotelemetry. Possible reasons for
misdiagnosis mentioned in the papers were bizarre presenting
symptoms and the presence of a psychiatric history.44–45 46 Nearly
a third of the recorded deaths at follow-up (13/47) were by sui-
cide. Other causes of death included immobility (without a new
organic diagnosis) (n = 2), vascular disease (n = 7), and cancer
(n = 8, one brain tumour).
Discussion
In the study of misdiagnosis of conversion symptoms or hysteria
the overall pooled proportion for the whole period was 8.4%
(7.1% to 9.9%). This overall figure, however, disguises a change
over time from 29% in the 1950s and 17% in the 1960s to a con-
sistently low rate of 4% for every decade since then.
There are two possible explanations for this decline. Firstly, it
could be that diagnostic methods could have improved. Against
this hypothesis, however, is the observation that the five yearly
misdiagnosis rate fell to 4.4% (2.1% to 9.2%) in the period
1970-4, which is before computerised tomography became gen-
erally available.48 So although modern investigations such as
neuroimaging and video electroencephalography are likely to
have increased the diagnostic accuracy in more recent studies,
our data suggest that they have not been as important as previ-
ously believed. This interpretation is supported by the fact that
many of the misdiagnosed patients were rediagnosed with
conditions such as epilepsy and movement disorders, which even
now rely predominantly on a clinical diagnosis. Secondly, early
studies may have reported artefactually high rates of misdiagno-
sis because of poor study methods. In favour of this hypothesis is
the observation that the six studies that contributed results to
data from the 1950s and 1960s3–7 10 were all poor quality. Figure
2 shows that studies with poor case definition tended to have a
higher rate of misdiagnosis.
Although a 4% misdiagnosis rate could still be seen as too
high, it must be considered alongside rates for other neurologi-
cal and psychiatric conditions. For example, up to a quarter of
patients with a diagnosis of epilepsy have other conditions, most
commonly syncope.49 In another study, 8% of patients with a
diagnosis of multiple sclerosis were later found to have
conversion disorder, illustrating that misdiagnosis can also hap-
pen in the opposite direction.50
Patients can have both disease and conversion symptoms.
Failure to distinguish studies of comorbidity from true misdiag-
nosis of organic disease is an error noted in some of the papers
reviewed.3
Limitations
We have outlined the limitations of the component studies
reported in this review, including poor definition of the
symptoms studied, retrospective study design, cohorts recruited
from tertiary, predominantly inpatient settings, and inadequate
methods of diagnostic re-evaluation.
We included only studies published since 1965. Some studies
were published before this date.51–55 They were of variable quality
with misdiagnosis rates of between 13% and 17%, figures that do
not necessitate any change in our conclusions. We did not
include studies of other somatoform disorders or of dysphonia
and globus pharyngis (which are both conversion symptoms).
We are not aware of any studies of patients with these diagnoses
that would alter our general conclusions.56 We may have
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underestimated the latency between diagnosis and publication
for four studies where information was unavailable,5 17 18 27
although this would tend to emphasise rather than contradict
our conclusions. Finally, we acknowledge the conceptual
limitations of defining a symptom as being “unexplained by dis-
ease.” While we have used this to mean no conventionally
defined pathology, we recognise that all symptoms must
ultimately have neurobiological correlates as illustrated by recent
functional imaging studies of patients with conversion
symptoms.57
Implications
In modern studies the proportion of patients diagnosed as hav-
ing conversion symptoms that subsequently turn out to be due to
disease is low. The decline from earlier reports of a high rate
probably reflect the poor methods used in earlier studies more
than an improvement in modern diagnosis resulting from the
availability of brain imaging. Misdiagnosis may be more
common in patients with gait and movement disorders and in
those with a psychiatric history.
While concern about misdiagnosis may be helpful in encour-
aging a thorough assessment, it may be unhelpful by leading to
overinvestigation and delayed treatment for what are potentially
reversible conversion symptoms. We suggest that the balance
between concern about missing disease and neglecting the value
of a positive diagnosis of a reversible conversion symptom needs
to be redressed.
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